Evidence map›Paper›PMID 42499201›Full record

ArticleCancer medicine2026

Creation of a Retinoblastoma Registry in a Resource-Limited Country in Sub-Saharan Africa.

Benjamin Abaidoo, Vera Adobea Essuman, Helen Dimaras, Kwesi Nyan Amissah-Arthur, Vera Mawusime Beyuo, Doreen Amankwaa-Frempong, Peter Forson Ackah, Andrea Nimako, Dziffa-Bella Imelda-Odille Ofori-Adjei, Naa Naamuah Tagoe and 14 more

Abstract read
In one paragraph

Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Benjamin AbaidooOphthalmology Unit, Department of Surgery, University of Ghana Medical School, Accra, Ghana.ORCID https://orcid.org/0000-0003-2268-9032
Vera Adobea EssumanOphthalmology Unit, Department of Surgery, University of Ghana Medical School, Accra, Ghana.ORCID https://orcid.org/0000-0001-8529-6362
Helen DimarasDepartment of Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID https://orcid.org/0000-0003-1164-2001
Kwesi Nyan Amissah-ArthurSt. Thomas Eye Hospital, Accra, Ghana.ORCID https://orcid.org/0000-0003-2018-2043
Vera Mawusime BeyuoEye Department, Korle Bu Teaching Hospital, Accra, Ghana.ORCID https://orcid.org/0009-0002-0689-1943
Doreen Amankwaa-FrempongEye Department, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Peter Forson AckahEye Department, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Andrea NimakoEye Department, Korle Bu Teaching Hospital, Accra, Ghana.ORCID https://orcid.org/0009-0001-2873-8109
Dziffa-Bella Imelda-Odille Ofori-AdjeiEye Department, Korle Bu Teaching Hospital, Accra, Ghana.ORCID https://orcid.org/0000-0003-0111-7545
Naa Naamuah TagoeEye Department, Korle Bu Teaching Hospital, Accra, Ghana.ORCID https://orcid.org/0000-0001-5409-9884
Lauretta Pinamang Owusu-AsareEye Department, Korle Bu Teaching Hospital, Accra, Ghana.
Yaw Akye EssumanEye Department, Korle Bu Teaching Hospital, Accra, Ghana.ORCID https://orcid.org/0009-0001-0179-4119
Isabella Perpetual ArthurEye Department, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Gloria Gyamaa KyeremehEye Department, Komfo Anokye Teaching Hospital, Kumasi, Ghana.ORCID https://orcid.org/0009-0005-6911-7682
Louis Oteng-GyimahAnglican Eye Clinic, Jachie, Bosomtwe, Ghana.ORCID https://orcid.org/0000-0002-8664-459X
Gilbert Batieka BonsaanaDepartment of Ophthalmology, School of Medicine, University for Development Studies, Tamale, Ghana.ORCID https://orcid.org/0000-0003-3362-7881
Judith SimonDepartment of Ophthalmology, School of Medicine, University for Development Studies, Tamale, Ghana.
Benedicta Appiah-ThompsonEye Department, Cape Coast Teaching Hospital, Cape Coast, Ghana.
James Fiifi AddyCure Blindness Project, Ghana Office, Accra, Ghana.
Adolf OllennuOrbis International, Ghana Office, Accra, Ghana.
Lorna Awo RennerDepartment of Child Health, University of Ghana Medical School, Accra, Ghana.ORCID https://orcid.org/0000-0001-7902-773X
Chris GuureDepartment of Biostatistics, School of Public Health, University of Ghana, Accra, Ghana.ORCID https://orcid.org/0000-0001-6768-8215
Vivian PaintsilSchool of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.ORCID https://orcid.org/0000-0002-8965-0549
Sally PeprahOffice of Surveillance and Epidemiology, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRetinoblastoma (RB) is the most common ocular tumor in young children, originating from the developing retina, with the burden remaining higher in regions of low socio-demographic index. A registry of RB is essential for creating effective referral networks for evaluating treatment patterns and contributing to the global pool of knowledge.

aimTo develop an RB registry for Ghana and assess its feasibility and acceptability.

methodsAn online REDCap (Research Electronic Data Capture) database was created as a registry of children diagnosed with RB in Ghana. Data completeness across core variables was analyzed and presented as a percentage. Technical, operational feasibility, and acceptability of the registry were assessed. Qualitative in-depth interviews were conducted with 2 users from each center to assess acceptability. At each treatment center, a registry lead was trained to enter data into the REDCap database.

resultsData were entered, aggregated, and stored in the REDCap database. Data captured included: socio-demographic and clinical information, clinical staging and systemic evaluations, histopathological risk assessment and staging, and final treatment outcomes. With reliable hardware performance, safe software features, and steady network connectivity backed by offline caching, the registry proved technically and operationally feasible. The average data entry time was 15 min, and the data quality was over 70%. Acceptability was emphasized in user interviews by themes of completeness and data quality, timeliness and workflow integration, and correctness and clinical relevance.

conclusionsThe registry demonstrated strong technical and operational feasibility, with efficient workflows and reliable infrastructure. High data quality and user-validated acceptability underscore its integration into routine clinical practice.

Indexed as

RegistriesRetinal NeoplasmsRetinoblastomaChildChild, PreschoolDatabases, FactualFemaleGhanaHumansInfantMaleResource-Limited Settingschildrencongenitaldatabaseocular cancerregistryretinoblastoma

Identifiers

PMID42499201
PMCPMC13400982

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.